20 (AIDX) Payables (2024 - 2026)

20's (AIDX) quarterly Payables came in at $1.3 million in Q1 2026, up 42.22% on a QoQ basis from $943156.0 in Q4 2025.

20 (AIDX) Payables (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Payables data on file, last reported at $1.3 million in Q1 2026.

Quarterly Payables changed N/A year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $943156.0, up 153.33% from the prior year.
Payables improved to $1.3 million in Q1 2026, from $943156.0 in the prior quarter.
In the past five years, Payables ranged from a high of $1.3 million in Q1 2026 to a low of $372303.0 in Q4 2024.
A 3-year average of $885617.7 and a median of $943156.0 in 2025 frame the typical range for Payables.
The widest YoY moves for Payables: up 153.33% in 2025, down 153.33% in 2025.
Tracing AIDX's Payables over 3 years: stood at $372303.0 in 2024, then soared by 153.33% to $943156.0 in 2025, then surged by 42.22% to $1.3 million in 2026.
The last three Payables figures came in at $1.3 million (Q1 2026), $943156.0 (Q4 2025), and $372303.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	5.89 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	2.00 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	2.51 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	587.50 Mn
10	20	5.55 Mn	1.00 Mn	304,727.00	1.15 Mn

Download Data